TRIM6 and acute myeloid leukemia: In future studies, we plan to establish xenograft mouse models to observe the effects of TRIM6 overexpression on tumor growth and disease progression, thereby enabling a more comprehensive evaluation of the therapeutic potential of TRIM6 in the context of AML.